Edgewise Therapeutics's market cap is currently $2.68B. The company's EPS TTM is $-1.491; its P/E ratio is ―; Edgewise Therapeutics is scheduled to report earnings on February 20, 2025, and the estimated EPS forecast is $-0.42. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Gross Profit	$ -1.73M	$ -538.00K	$ -272.00K	$ -185.00K	$ -123.00K
Operating Income	$ -114.36M	$ -22.08M	$ -43.22M	$ -17.19M	$ -9.92M
EBITDA	$ -112.81M	$ -67.10M	$ -42.94M	$ -17.01M	$ -9.80M
Net Income	$ -100.16M	$ -15.40M	$ -42.14M	$ -17.05M	$ -9.49M
Balance Sheet
Cash & Short-Term Investments	$ 318.39M	$ 351.95M	$ 280.79M	$ 129.09M	$ 23.65M
Total Assets	$ 340.04M	$ 367.10M	$ 285.23M	$ 131.14M	$ 24.54M
Total Debt	$ 5.41M	$ 4.41M	$ 0.00	$ 160.21M	$ 40.26M
Net Debt	$ -80.68M	$ -347.54M	$ -280.79M	$ 55.30M	$ 16.61M
Total Liabilities	$ 21.20M	$ 20.39M	$ 10.85M	$ 164.56M	$ 41.39M
Stockholders' Equity	$ 318.83M	$ 346.72M	$ 274.38M	$ -33.42M	$ -16.85M
Cash Flow
Free Cash Flow	$ -97.69M	$ -58.18M	$ -34.17M	$ -14.84M	$ -9.35M
Operating Cash Flow	$ -91.95M	$ -52.63M	$ -33.51M	$ -14.63M	$ -9.17M
Investing Cash Flow	$ 102.89M	$ -70.58M	$ -242.23M	$ -24.38M	$ -180.00K
Financing Cash Flow	$ 53.17M	$ 129.64M	$ 186.38M	$ 120.28M	$ 24.80M

Currency in USD

Edgewise Therapeutics Earnings and Revenue History

Income Statement >

Edgewise Therapeutics Debt to Assets

Balance Sheet >

Edgewise Therapeutics Cash Flow

Cash Flow >

Edgewise Therapeutics Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing